Illumina Genome Analyzer IIx

The Illumina GAIIx was a pioneering next-generation sequencing (NGS) system, introduced in 2009, that significantly advanced genomic research by offering high-throughput and accurate sequencing capabilities. This instrument was instrumental in various applications, including whole-genome sequencing, transcriptome analysis, and epigenetic studies.

Key features of this sequencer included:

• High Data Output: Capable of generating up to 95 gigabases of data per run, facilitating comprehensive genomic analyses.

• Paired-End Sequencing: Enabled sequencing from both ends of DNA fragments, enhancing genome assembly and structural variant detection.

• Sequencing by Synthesis (SBS) Technology: Utilised Illumina's proprietary SBS chemistry for accurate base calling and high-quality data.

• Broad Application Range: Supported diverse applications such as whole-genome resequencing, RNA sequencing (RNA-Seq), ChIP-Seq, and DNA methylation studies.

The GAIIx was widely adopted in various scientific fields, including genomics, transcriptomics, and epigenetics. It was commonly utilised in academic research institutions, biotechnology companies, and pharmaceutical firms for large-scale sequencing projects. Notably, the Broad Institute expanded its fleet to 89 GAIIx systems in 2009, underscoring its prominence in high-throughput sequencing.

While the GAIIx has been succeeded by more advanced platforms, its impact on the biotechnology industry during its operational period was substantial, laying the groundwork for subsequent innovations in NGS technologies.